Evgen Pharma Share Price (EVG)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Evgen Pharma	LSE:EVG	London	Ordinary Share	GB00BSVYN304	ORD 0.25P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+0.00p	+0.00%	17.50p	17.00p	18.00p	17.50p	17.50p	17.50p	492	08:00:00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	0.0	-3.2	-6.3	-	12.82

Related Shares
GlaxoSmithKline (GSK), AstraZeneca (AZN), Valirx (VAL), Port Erin (PEBI)

Evgen Pharma (EVG) Latest News

Evgen Pharma News

Date	Time	Source	Headline
21/6/2017	10:00	UKREG	Evgen Pharma PLC Posting of Annual Report and AGM Notice
21/6/2017	07:28	ALNCF	Alliance News Flash Headline
21/6/2017	07:15	RNSNON	Evgen Pharma PLC Hardman Research: Making clinical progress
13/6/2017	13:27	ALNC	Evgen Pharma Loss Widens As SFX-01 Clinical Trials Progress
13/6/2017	07:00	UKREG	Evgen Pharma PLC Full Year Results
01/6/2017	09:55	ALNC	Evgen Pharma SFX-01 Trials Progressing With No Safety Issues To Date
01/6/2017	07:00	UKREG	Evgen Pharma PLC Compassionate Use Programme and Trials Update
25/5/2017	07:02	UKREG	Evgen Pharma PLC Notice of Preliminary Results
03/4/2017	14:15	UKREG	Evgen Pharma PLC Directorate Change
28/3/2017	15:02	ALNC	Evgen Pharma Granted US Patent Covering Lead Product SFX-01

More Evgen Pharma News

Evgen Pharma Takeover Rumours

Evgen Pharma (EVG) Share Charts

1 Year Evgen Pharma Chart

1 Month Evgen Pharma Chart

Intraday Evgen Pharma Chart

Evgen Pharma (EVG) Discussions and Chat

Evgen Pharma Forums and Chat

Date	Time	Title	Posts
21/6/2017	16:16	Evgen Pharma: Developing Sulforaphane to treat Stroke, MS and Cancer	29
13/6/2017	09:45	Evgen Pharma Interview	-
29/11/2016	08:27	Evgen Pharma (EVG) chief executive Stephen Franklin	39
24/8/2016	15:30	EVG	39
10/1/2016	18:58	Evgen Pharma PLC	47

Add a New Thread

Evgen Pharma (EVG) Most Recent Trades

No Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type

View all Evgen Pharma trades in real-time

Evgen Pharma (EVG) Top Chat Posts

Date	Subject
24/6/2017 09:20	Evgen Pharma Daily Update: Evgen Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker EVG. The last closing price for Evgen Pharma was 17.50p. Evgen Pharma has a 4 week average price of 15p and a 12 week average price of 15p. The 1 year high share price is 33p while the 1 year low share price is currently 14.75p. There are currently 73,272,591 shares in issue and the average daily traded volume is 26,442 shares. The market capitalisation of Evgen Pharma is £12,822,703.43. Read Full Thread Reply
15/2/2017 08:14	timbo003: This week's (unexpected) performance has to be worth an animated gif! I'm not sure what the catalyst is for this recent rise, a patent grant (even in the US) doesn't normally have an effect of this magnitude on the share price. Read Full Thread Follow Reply
25/7/2016 18:47	timbo003: Presumably this new article on Proactiveinvestor was the catalyst for the excitement today: http://www.proactiveinvestors.co.uk/companies/news/128572/evgen-pharma-and-the-power-of-plants-for-potential-drug-breakthrough-128572.html It's well written but contains no new news, so it wouldn't surprise me if the share price drifts back down again. I suspect the next significant news will be MRHA approval for the Metastatic breast cancer study Read Full Thread Follow Reply
30/10/2011 19:43	call-logger: Subject to the Court sanctioning the Scheme and the satisfaction of certain other outstanding conditions, it is expected that the last day for dealings in Evolution Shares will be 6 December 2011 and the Scheme will become effective on 7 December 2011. If you're selling, the takeover date doesn't really matter to you. The share price is now purely based on the market's view of Investec Read Full Thread Follow Reply
08/11/2009 18:17	plast: well if that is the result to the share price, then they can sell some more. Read Full Thread Follow Reply
08/1/2008 19:48	msy: No share price movement to the following news? BES could make full bid for Evolution if strategic alliance goes well LISBON (Thomson Financial) - Banco Espirito Santo could make a full bid for the Evolution Group, in which it bought a 9.95 pct stake yesterday, if the strategic alliance between the Portuguese bank and the UK broker goes well, the Daily Telegraph reported, without citing a source. According to the newspaper, BES bought the stake in Evolution to offer international clients access to the London market through the UK-based financial holding's investment arm. If the arrangement works well, BES may make an offer for the whole of the UK business which is worth 260 mln stg, the paper said. Yesterday, BES investment unit BESI said it acquired its 9.95 pct stake for around 26.1 mln stg (about 35.5 mln eur). Evolution might be attractive to a buyer because the volatile earnings from its investment banking business were offset by more steady profits from its asset-management business, gained when it bought Williams de Broe from ING in 2006, the paper added. Read Full Thread Follow Reply
11/10/2007 15:50	eastbourne1982: moving very strongly this afternoon and starting to build up some decent momemtum, could be the start of a recovery in the share price Read Full Thread Follow Reply
08/10/2007 11:58	eastbourne1982: any ideas what is going on here, pretty much at a 3 - 4 year in terms of share price, all seems very strange as there cannot be a lot wrong with this company, I will continue to hold, may just take a little longer to see £1.30 again !! Read Full Thread Follow Reply
28/3/2007 09:08	seagreen: Incredible change around in the shareholders register over the last couple of months with well known value seekers and activist shareholders famous for extracting value or seeking long term growth coming on board with large stakes and there is no way they have come on board because Evolution is the city darling especially after TXO etc Surely it means they think the sum of the parts and the cash must be worth a lot more than the current share price be it as one company or as individual companies...Anyway I have gone long a few to see what happens Read Full Thread Follow Reply
20/11/2004 18:55	maut too: Brokers' say (Filed: 20/11/2004) Brokers' updates are compiled by Hargreaves Lansdown. The stockbrokers' views summarised here are their own and not necessarily those of money.telegraph or Hargreaves Lansdown Evolution Hold at 154p, advises Credit Suisse First Boston (153p this week). Recent first-half results from the small investment bank showed strong progress being made, with revenues increasing by 126 per cent on the previous year. This revenue growth has translated into a signi. cant increase in pro. ts as a result of the group's operational gearing. Evolution continues to carve out a positive niche for itself, although the barriers to entry are low. CSFB believes the share price strength is deserved. Read Full Thread Follow Reply
28/11/2003 11:50	crossgate: I must admit that it appears the shares will not be going north in the short term due to the shortselling by EVG which in all honesty is a very common practice. But this has damaged the credibility of EVG and with that 6 million quid for the top brass it's time to call it a day. Once this little shortselling scandal is out of the way there may be a profit potential again in EVG particularly near the next results. My humblest apologies to the plonkers, but Ive not done bad out of these shares. Goood luck to those staying in. ps I fully agree with ranoszek that EVG have been doing the same trick with OMH for ages now and have really damaged their share price. Read Full Thread Follow Reply

Evgen Pharma share price data is direct from the London Stock Exchange

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:34 V: D:20170624 17:36:57